These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9848330)

  • 21. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors.
    Pautier P; Gutierrez-Bonnaire M; Rey A; Sillet-Bach I; Chevreau C; Kerbrat P; Morice P; Duvillard P; Lhommé C
    Int J Gynecol Cancer; 2008; 18(3):446-52. PubMed ID: 18494093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
    Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
    Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
    Lopes da Silva J; Luiz Renna N; Paulino E; de Melo AC
    Int J Gynecol Cancer; 2015 Jun; 25(5):786-91. PubMed ID: 25790041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
    Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
    Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
    Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
    J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
    Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
    Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
    Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
    Stuart-Harris R; Fox RM; Raghavan D; Coates AS; Hedley D; Levi JA; Woods RL; Tattersall MH
    Thorax; 1985 May; 40(5):346-50. PubMed ID: 2410994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
    Smith EB; Clarke-Pearson DL; Creasman WT
    Am J Obstet Gynecol; 1984 Dec; 150(8):927-31. PubMed ID: 6542313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
    Hong W; Zhang R; Liu L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity.
    Gershenson DM; Wharton JT; Kline RC; Larson DM; Kavanagh JJ; Rutledge FN
    Cancer; 1986 Dec; 58(12):2594-9. PubMed ID: 2430686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nondysgerminomatous tumors of the ovary treated with cisplatin, vinblastine, and bleomycin: long-term results.
    De Palo G; Zambetti M; Pilotti S; Rottoli L; Spatti G; Fontanelli R; Musumeci R; Kenda R; Bombardieri E; Stefanon B
    Gynecol Oncol; 1992 Nov; 47(2):239-46. PubMed ID: 1281804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
    Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
    J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical blindness and seizures possibly related to cisplatin, vinblastine, and bleomycin treatment of ovarian dysgerminoma.
    Young DC; Mitchell A; Kessler J; Christman JE
    J Am Osteopath Assoc; 1993 Apr; 93(4):502-4, 507. PubMed ID: 7683015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.